Reactivation of a hepatitis B virus surface-antigen mutant following an autologous stem-cell transplant for multiple myeloma in an anti-HBc-negative patient

Joseph M Lewis; Ian J Hart; Emmanuel Nsutebu

首页> 外文期刊>JMM Case Reports >Reactivation of a hepatitis B virus surface-antigen mutant following an autologous stem-cell transplant for multiple myeloma in an anti-HBc-negative patient

【24h】

Reactivation of a hepatitis B virus surface-antigen mutant following an autologous stem-cell transplant for multiple myeloma in an anti-HBc-negative patient

机译：自体干细胞移植治疗抗HBc阴性患者的多发性骨髓瘤后乙型肝炎病毒表面抗原突变体的重新激活

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Hepatitis B virus (HBV) surface-antigen mutants can present diagnostic difficulties when they are not recognized by commercial assays; HBV infection with undetectable core antibody is also described.

机译：乙型肝炎病毒（HBV）表面抗原突变体在商业分析无法识别时会带来诊断上的困难。还描述了无法检测到的核心抗体对HBV的感染。

著录项

来源
《JMM Case Reports》 |2015年第3期|共4页
作者
Joseph M Lewis; Ian J Hart; Emmanuel Nsutebu;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类微生物学;
关键词
入库时间 2022-08-18 15:57:24

相似文献

外文文献
中文文献
专利

1. Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection [J] . MyaD.H.T., HanS.T., LinnY.C., Annals of oncology: official journal of the European Society for Medical Oncology . 2012,第2期

机译：乙型肝炎再激活的风险以及新型药物和干细胞移植在多发性乙型肝炎病毒感染患者中的作用
2. Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients withn hepatitis B virus (HBV) infection [J] . D. C. L. Tan Annals of Oncology . 2012,第2期

机译：乙型肝炎再激活的风险以及新型药物和干细胞移植在多发性乙型肝炎病毒感染的骨髓瘤患者中的作用
3. High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): A randomised, open-label, phase 3 trial [J] . CookG., WilliamsC., BrownJ.M., The lancet oncology . 2014,第8期

机译：大剂量化疗加自体干细胞移植作为巩固疗法治疗先前自体干细胞移植后复发的多发性骨髓瘤患者（NCRI骨髓瘤X复发[强化试验]）：一项随机，开放标签的3期试验
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Natural Killer Cell Recovery and Disease Outcomes After Autologous Stem Cell Transplantation in Multiple Myeloma [D] . Keruakous, Amany R. 2021

机译：自然杀手细胞回收和疾病结果在多发性骨髓瘤中的自体干细胞移植后
6. Cyclophosphamide thalidomide and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results [O] . Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, 2012

机译：环磷酰胺沙利度胺和地塞米松作为新诊断为多发性骨髓瘤患者的自体干细胞移植的诱导疗法：MRC骨髓瘤IX随机试验结果
7. Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results [O] . Morgan, Gareth J., Davies, Faith E., Gregory, Walter M., 2011

机译：环磷酰胺，沙利度胺和地塞米松作为新诊断为多发性骨髓瘤患者的自体干细胞移植的诱导疗法：MRC骨髓瘤IX随机试验结果

Reactivation of a hepatitis B virus surface-antigen mutant following an autologous stem-cell transplant for multiple myeloma in an anti-HBc-negative patient

摘要

著录项

相似文献

相关主题

期刊订阅